Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Harmonizing biosecurity oversight for gene synthesis

Nature Biotechnology volume 28, pages 20–22 (2010)Cite this article

Subjects

To the Editor:

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. International Association Synthetic Biology. Code of conduct for best practices in gene synthesis. <http://tinyurl.com/iasbcode/> (2009).

  2. International Gene Synthesis Consortium. Harmonized screening protocol: gene sequence & customer screening to promote biosecurity. <http://www.genesynthesisconsortium.org/Harmonized_Screening_Protocol.html> (2009).

  3. Department of Health and Human Services. Screening framework guidance for synthetic double-stranded DNA providers. Fed. Regist. 74, 62319–62327 <http://edocket.access.gpo.gov/2009/E9-28328.htm> (2009).

  4. National Science Advisory Board for Biosecurity. Addressing biosecurity concerns related to the synthesis of select agents. <http://oba.od.nih.gov/biosecurity/pdf/Final_NSABB_Report_on_Synthetic_Genomics.pdf> (2006).

  5. International Association Synthetic Biology. Workshop report: technical solutions for biosecurity in synthetic biology. <http://tinyurl.com/iasbreport/> (2008).

  6. Check Hayden, E. Nature 461, 22 (2009).

    Article  Google Scholar 

  7. Anonymous. World's top gene synthesis companies establish tough biosecurity screening protocol. <http://www.einpresswire.com/article/56890-world-s-top-gene-synthesis-companies-establish-tough-biosecurity-screening-protocol> (2009).

  8. Wadman, M. US drafts guidelines to screen genes. Nature News <http://www.nature.com/news/2009/091204/full/news.2009.1117.html> (4 December 2009).

  9. Maurer, S., Fischer, M., Schwer, H., Stähler, C. & Stähler, P. Working paper: making commercial biology safer: what the gene synthesis industry has learned about screening customers and orders. <http://gspp.berkeley.edu/iths/Maurer_IASB_Screening.pdf> (2009).

  10. Tozzi, J. Watchdogs: shell schemes are on the rise. BusinessWeek.com <http://www.businessweek.com/smallbiz/content/nov2009/sb2009115_791003.htm> (5 November 2009).

Download references

Author information

Affiliations

  1. Entelechon GmbH, Regensburg, Germany

    Markus Fischer

  2. Goldman School of Public Policy, University of California, Berkeley, California, USA

    Stephen M Maurer

Authors
  1. Markus Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen M Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen M Maurer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fischer, M., Maurer, S. Harmonizing biosecurity oversight for gene synthesis. Nat Biotechnol 28, 20–22 (2010). https://doi.org/10.1038/nbt0110-20

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0110-20

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing